← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

#	Name	Funds holding	Growth	Growth %	Fund value
51	51 DELISTED CERo Therapeutics CERO	–	–	–	–
52	52 Calidi Biotherapeutics CLDI $2.25M	–	–	–	–
53	53 Cellectis CLLS $111M	–	–	–	–
54	54 Coya Therapeutics COYA $102M	–	–	–	–
55	55 Caribou Biosciences CRBU $49.8M	–	–	–	–
56	56 DELISTED CARGO Therapeutics CRGX	–	–	–	–
57	57 CRISPR Therapeutics CRSP $4.98B	–	–	–	–
58	CYAD 58 DELISTED Celyad Oncology SA American Depositary Shares CYAD	–	–	–	–
59	DBTX 59 DELISTED Decibel Therapeutics, Inc. Common Stock DBTX	–	–	–	–
60	60 Precision BioSciences DTIL $170M	–	–	–	–
61	61 enGene Therapeutics ENGN $115M	–	–	–	–
62	62 Estrella Immunopharma ESLA $23.3M	–	–	–	–
63	63 FibroBiologics FBLG $7.08M	–	–	–	–
64	64 4D Molecular Therapeutics FDMT $711M	–	–	–	–
65	FRLN 65 DELISTED Freeline Therapeutics Holdings plc American Depositary Shares FRLN	–	–	–	–
66	66 DELISTED Generation Bio GBIO	–	–	–	–
67	67 CytoMed Therapeutics GDTC $10.4M	–	–	–	–
68	GMDA 68 DELISTED Gamida Cell Ltd. Ordinary Shares GMDA	–	–	–	–
69	69 Genprex GNPX $1.88M	–	–	–	–
70	70 Genenta Science GNTA $32.3M	–	–	–	–
71	GRCL 71 DELISTED Gracell Biotechnologies Inc. American Depositary Shares GRCL	–	–	–	–
72	GRML 72 Greenland Mines Ltd GRML $92.9M	–	–	–	–
73	73 Fractyl Health GUTS $55.2M	–	–	–	–
74	74 Immix Biopharma IMMX $720M	–	–	–	–
75	75 Immatics IMTX $1.09B	–	–	–	–